13F Data
13F filer · CIK 1388325

NOVO HOLDINGS A/S

HELLERUP, G7 · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$1.7B
+$488.0M vs prior
Positions
25
New / sold out
6 / 3
Added / reduced
2 / 8
Turnover
11.6%
buys $396.8M · sells $170.8M
Top-10 weight
73.5%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewHEMAB THERAPEUTICS HLDGS INC+4,180,550–+$153.6M
NewAVALYN PHARMACEUTICALS INC+3,883,289–+$127.8M
NewFLOOR & DECOR HLDGS INC+797,000–+$47.3M
NewALUMIS INC+1,100,000–+$31.0M
NewDYNE THERAPEUTICS INC+960,394–+$21.3M
NewINSMED INC+120,723–+$12.9M
AddedVIRIDIAN THERAPEUTICS INC+135,000+6.8%+$2.5M
AddedBRIDGEBIO ONCOLOGY THERAPEUT+64,077+2.9%+$488.3K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outAPOGEE THERAPEUTICS INC-450,000-100.0%$-37.9M
Sold outBIOMARIN PHARMACEUTICAL INC-660,000-100.0%$-37.3M
ReducedMIRUM PHARMACEUTICALS INC-200,000-15.1%$-23.4M
ReducedARRIVENT BIOPHARMA INC-442,142-22.8%$-15.4M
ReducedENLIVEN THERAPEUTICS INC-280,000-21.9%$-14.2M
ReducedPHARVARIS N V-350,000-20.0%$-12.1M
ReducedCRINETICS PHARMACEUTICALS IN-230,000-14.8%$-8.6M
Sold outVALNEVA SE-1,057,421-100.0%$-6.6M
ReducedCELLDEX THERAPEUTICS INC NEW-175,000-14.6%$-6.5M
Reduced4D MOLECULAR THERAPEUTICS IN-401,559-11.0%$-5.3M
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $597.0MQ3 2013: $403.8MQ4 2013: $1.3BQ1 2014: $1.6BQ2 2014: $2.0BQ3 2014: $1.0BQ4 2014: $1.2BQ1 2015: $1.2BQ2 2015: $1.4BQ3 2015: $967.9MQ4 2015: $1.0BQ1 2016: $912.5MQ2 2016: $952.6MQ3 2016: $1.1BQ4 2016: $1.1BQ1 2017: $939.1MQ2 2017: $835.8MQ3 2017: $768.3MQ4 2017: $713.4MQ1 2018: $797.4MQ2 2018: $994.6MQ3 2018: $1.3BQ4 2018: $710.3MQ1 2019: $676.0MQ2 2019: $713.8MQ3 2019: $583.7MQ4 2019: $1.6BQ1 2020: $1.5BQ2 2020: $1.5BQ3 2020: $2.0BQ4 2020: $2.3BQ1 2021: $2.4BQ2 2021: $2.3BQ3 2021: $1.9BQ4 2021: $2.1BQ1 2022: $1.9BQ2 2022: $2.0BQ3 2022: $2.1BQ4 2022: $1.6BQ1 2023: $1.5BQ2 2023: $1.3BQ3 2023: $1.4BQ4 2023: $1.5BQ1 2024: $1.4BQ2 2024: $1.9BQ3 2024: $2.0BQ4 2024: $1.7BQ1 2025: $1.3BQ2 2025: $1.4BQ3 2025: $1.6BQ4 2025: $1.3BQ1 2026: $1.2BQ2 2026: $1.7B
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1EDGEWISE THERAPEUTICS INCCOM5,350,000$217.4M12.62%
2ASML HOLDING N VN Y REGISTRY SHS94,946$188.9M10.97%
3HEMAB THERAPEUTICS HLDGS INCCOM SHS4,180,550$153.6M8.92%
4BROOKFIELD CORPCL A LTD VT SH3,496,245$149.5M8.68%
5MAPLIGHT THERAPEUTICS INCCOM3,686,622$132.1M7.67%
6MIRUM PHARMACEUTICALS INCCOM1,125,000$131.7M7.65%
7AVALYN PHARMACEUTICALS INCCOM SHS3,883,289$127.8M7.42%
8SALESFORCE INCCOM393,187$61.6M3.58%
9ARRIVENT BIOPHARMA INCCOM1,500,000$52.1M3.03%
10ENLIVEN THERAPEUTICS INCCOM1,000,000$50.8M2.95%
15 more rows. Subscribe for $29/month to see every row, download the data and use the API.